FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 SELF-TEST

MDR report key: 14429006 · Received May 18, 2022

Report

Report Number
1221359-2022-02191
Event Type
Malfunction
Date Received
May 18, 2022
Date of Event
April 28, 2022
Report Date
June 3, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.

Additional Manufacturer Narrative · 0

ADDITIONAL DATA: D4(EXPIRATION DATE). THE SUPPLEMENTAL REPORT IS BEING SUBMITTED TO PROVIDE THE INVESTIGATION CONCLUSION. TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 180075 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160 / LOT 180075 AND DEVICE PART NUMBER 195-430H / LOT 178675. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 180075 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE.

Description of Event or Problem · 0

THE CUSTOMER REPORTED AN UNCONFIRMED FALSE POSITIVE RESULT WITH BINAXNOW COVID-19 AG SELF-TEST ON (B)(6) 2022. THE CUSTOMER STATED THAT SHE WENT TO THE DOCTOR CLINIC AND GOT A NEGATIVE RESULT, BUT THEN SHE GOT TESTED POSITIVE WITH BINAXNOW SELFTEST. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED. ADDITIONALLY; THE CUSTOMER CONFIRMED THERE WAS NO DELAY OR IMPACT IN THE PATIENT'S TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2763887 BINAXNOW COVID-19 SELF-TEST LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC 180075 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 72 YR Female